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Abstract:
Urologic and gynecologic surgeons are the top utilizers of robotic surgery; however,
non-obstetrical robotic-assisted laparoscopic surgery (RALS) in pregnant patients is infrequent.
A systematic literature review was performed to ascertain the frequency, indication and
complications of RALS in pregnancy. Results showed thirty-eight pregnancies from eleven
publications between 2008-2020. Five cases were for urologic indication and thirty-three for
gynecologic indication. Minimal surgical alterations were required. Although no adverse
maternal-fetal outcomes were reported, there are not enough cases published to determine
safety. This review demonstrates the feasibility of RALS for the pregnant population in the
hands of competent robotic surgeons.

Introduction:
The use of robotic-assisted laparoscopic surgery (RALS) has become a mainstay of many
surgical specialties. As more specialties have adopted its use and surgeons began to expand its
reach, RALS has become a common option for many patients for various indications, including
intraperitoneal, retroperitoneal, thoracic, and pelvic procedures. Currently, urological and

gynecologic surgeons utilize RALS at the highest frequency and for a wide breadth of
indications.1 Uniquely, these specialties’ pelvic procedures adapt well to robotic surgery, as it
facilitates visualization and manipulation within a confined space. Despite its common use by
gynecologists, the incorporation of RALS into the care of pregnant patients is rare. Historically,
there have been concerns that the unique parameters necessitated by laparoscopic surgery
were incompatible with the physiologic changes in pregnancy. Laparoscopy has since been
deemed relatively safe,2 with modest adjustments to compensate for the gravid physiology and
anatomy, yet the robotic iteration of this technique lags behind. One in 500 women require
non-obstetrical intraperitoneal surgery during pregnancy; 64.8% of these surgical interventions
are performed laparoscopically. 3 Herein, a systematic literature review was performed in order
to quantify the application of RALS in pregnant patients, catalogue the types of indications for
which it was employed, and review any complications of this technique thus far.

Methods:
We conducted a search using Ovid MEDLINE, PubMed, and Scopus from 2000 to January
21, 2020 as the da Vinci surgical system was approved around 2000 by the Food and Drug
Administration. Relevant papers addressing robotic surgery in pregnancy were identified. No
limitations were made based on study design or language. We adopted the following search
terms: (pregnancy OR antepartum OR pregnan* OR matern* OR obstetric* ) AND ( (
robotic AND surgical AND procedures ) OR ( robotic AND surgery ) OR ( ( robot* OR ( ( (

robot-assisted ) OR ( robotic-assisted ) ) AND laparoscop* ) ) AND ( ( minimally AND
invasive AND surgery ) OR ( minimally AND invasive AND surgical AND procedures ) ) ) OR (
robot-assisted AND surgery ) ) OR ( "da vinci" OR davinci ) ) ). The systematic review followed
the Preferred Reporting Items of Systematic Reviews and Meta-analysis (PRISMA) guidelines. 4
See appendix for the full search strategies.
The search yielded 1298 articles. Eligibility of the studies was independently reviewed
by two authors (C.C. and J.G.). Studies were included that addressed non-obstetric
transabdominal robotic surgery occurring during pregnancy. Studies including robotic cerclage
placement, robotic fetoscopic surgery, robotic surgery for ectopic pregnancy, robotic surgery
postpartum and studies without detailed clinical data were excluded. Disagreements were
resolved by deliberation with a third reviewer (H.A.K). The reference lists of all included studies
were examined to help identify studies not captured by the initial search. A total of 11 studies
were included in the final literature review (Figure 1).

Results:
Thirty-eight patients who underwent RALS during pregnancy met the inclusion criteria in
eleven publications (Table 1). The mean maternal age was 30.0 + 6.3 years with 75%
multiparous (n=27) and 25% primiparous (n=9). All of the RALS occurred in the second trimester
with a mean gestational age of 18.7 weeks (range: 14-23) (Table 1). Mode of entry into the

abdomen was reported in 8 of the 11 publications. Three reported using Veress needle, 3 using
direct entry, and 2 Hasson technique (Table 2). Seven of the 11 publications (63.6%) endorsed
maintaining a pneumoperitoneum less than or equal to 12mmHg. Estimated blood loss (EBL)
ranged from 0 cc to 350cc. EBL was < 50 cc for 83.3% (30/36), 51 to 200 cc for 13.8% (5/36), and
> 200 cc for 2.7% (1/36) of patients. Mean surgical duration was 104 minutes (range: 60-270).
Discharge from the hospital was on or before postoperative day (POD) 1 for 89% of patients
(25/28) with only 11% (3/28) discharged beyond POD 1 (range: POD4-POD6). No intraoperative
maternal or fetal complications were recorded during any of the surgeries (Table 1).
The indication for RALS was ovarian in 33 (87%) and urologic in 5 (13%). The types of
RALS performed for the ovarian category were as follows: ovarian cystectomy (n=25, 76.4%),
oophorectomy (n=5, 14.7%), salpingo-oophorectomy (n=3, 8.8%). One patient received both
left salpingo-oophorectomy and right partial ovarian cystectomy. Of these cases, 3 performed
an omentectomy (9.1%), 2 performed pelvic washings (6.1%), and 1 performed a bilateral pelvic
lymph node dissection (3.0%). Additionally, one publication had a series of nineteen cases and
the data was reported in aggregate; they did not report standard deviation for gestational age
at surgery and surgical duration, so these standard deviations could not be calculated in our
review.5 The types of RALS performed for the urologic category included adrenalectomy (n=3,
60.0%) and partial nephrectomy (n=2, 40%). The indications for the adrenalectomies were
pheochromocytoma (n=1), Cushing syndrome (n=1), and subclinical Cushing syndrome ( n=1).
The recorded postoperative surgical complications were one postoperative pneumonia
requiring readmission and antibiotics, and one patient complaining of pain at the trocar sites at

2 weeks postoperatively. Six of the thirty-eight patients (15.7%) had malignant pathology and
one underwent chemotherapy during pregnancy. 6
Obstetrical outcomes were reported for a limited number of cases. Eight patients had a
vaginal delivery and 4 had cesarean delivery with 2 of them being scheduled (1 for cancer
biopsies at time of cesarean section and 1 for unspecified indication). The mean gestational
age at delivery was 38.3 weeks, with only 2 patients delivering < 37 weeks. Neonatal outcomes
were reported for a limited number of cases (n=11), and all had a healthy neonate at delivery.
There was one case of preterm premature rupture of membranes at 30 weeks for which the
RALS was done at 19 weeks. However, the neonatal outcome was not reported for this case.

Discussion:
Approximately 1 in 500 women will require non-obstetrical abdominal surgery during
their pregnancy, most commonly for appendicitis, cholecystitis and small bowel obstruction. 7-9
The most common gynecologic indication is adnexal masses, which occur at a rate between
1/81 and 1/6000 pregnancies.10 Persistent masses pose a clinical challenge on whether to
observe or intervene, but literature shows between 2% and 6% of these masses are
malignant.10 Management of ovarian masses is operative based on persistence, size and
ultrasound characteristics. 11 Urologically, pheochromocytoma occurs in 1 in 50,000

pregnancies, and renal cell carcinoma in women of child bearing age occur < 5/100,000 cases
per year.12,13
Since its inception, robotic surgery has been rapidly incorporated into the repertoires of
surgeons across the nation since its approval. Although results vary depending on the surgery
type, evidence often shows shortened duration of hospital stay, lower conversion rates, and
lower blood loss. 14-16 The three-dimensional visualization and dynamic articulation seem well
suited for performing surgery while sharing the abdomen with a gravid uterus. Our systematic
review demonstrates low implementation of robotic surgery for non-obstetrical indications in
pregnant patients, with only thirty-eight cases in the last twenty years, and nineteen of those
cases representing a single institution experience. Even rarer were urological indications,
representing only 5 of the thirty-eight cases within the literature.
It is not unprecedented for newer techniques to lag behind when it comes to their
application in the pregnant patient populations. In fact, laparoscopic surgery itself was
suspected to be a contraindication in pregnancy in general. It was hypothesized that the
pneumoperitoneum necessary for laparoscopy would endanger both the mother and fetus.
Specifically, the carbon dioxide exposure was thought to be harmful to the developing fetus.
For the pregnant patient, there were concerns that the increased intraabdominal pressure from
the pneumoperitoneum would compress the inferior vena cava (IVC), dampen venous return,
and cause insufficient ventilation due to the intraabdominal pressure exerted on the
diaphragm.17,18 However, it has since been shown that laparoscopic surgery does not entail
additional risk, and was superior in length of stay, diet advancement, and narcotic use.2 The

use of the robot builds on the advantages of laparoscopy while not demanding any additional
parameters that could pose risk to patient or fetus. Specifically, its superior visualization,
ergonomic movements, tremor filtration, and multiple degree articulations may prove useful
while navigating a gravid uterus using a reduced intraabdominal pressure. In fact, in nonpregnant patients, RALS has been shown to have similar operative time and conversion rates
when compared to traditional laparoscopy for adrenal surgeries. 14,19
Robotic-assisted obstetrical cases, specifically cerclage placement and resection of
ectopic pregnancies, were excluded from our systematic review. Recently, a large systematic
review with sixty-four patients undergoing robotic cerclages was already published.20
Additionally, because cerclage is performed on the uterus itself, it does not impose the same
unique parameters that are faced when the target of a procedure is elsewhere within the
abdominal cavity. Our rational for excluding ectopic pregnancies was due to the fact that the
fetus is not viable, and such cases do not share the unique challenges of the other
intraabdominal gestational RALS cases; such obstacles include manipulation around the gravid
uterus and prioritizing fetal viability. Additionally, multiple ectopic cases managed robotically
reported in the literature occur in the first trimester. 21-23 These cases do not entail the same
parameters of fetal risk, uteroplacental blood flow, and anesthesia implications.
Despite the paucity of cases within the literature for non-obstetrical RALS, there were
commonalities between them. All surgeries were performed within the second trimester. This is
expected, as the second trimester is following the completi on of organogenesis within the first
trimester and is before the third trimester wherein the gravid uterus presents a cumbersome

surgical obstacle. 2,24,25 Blood loss was also consistently low with 83.3% having an EBL <50. This
is in line with other literature often demonstrating lower EBL as a benefit of RALS. 1,14,16 Also
consistent with purported benefits of RALS, postoperative stay was generally short, with only 3
(11%) patients enduring hospitalization beyond POD day 1. Of note, all three of these cases had
a urologic indication: partial nephrectomy (n=2) and pheochromocytoma (n=1). Therefore, the
longer hospital stay in those cases may be due to the intrinsic nature of the operation and need
for post-operative monitoring rather than post-operative recovery.
Additionally, with regard to patient positioning, we acknowledge that there is little room
for adjustment, as many surgeries require predetermined patient position. In pregnant
patients, the gravid uterus places pressure on the IVC, impeding venous return and impact ing
fetal blood flow.26,27 Besides obvious anesthetic implications, positioning patients in supine can
worsen the hypotension and disrupt placental blood flow. Therefore, favoring positions such as
left lateral tilt and avoiding a full supine position can reduce the risk of adverse hemodynamic
changes.12,28,29 As many urologic and gynecologic procedures require Trendelenburg
positioning, this may be beneficial for both the patient and the fetus. However, in certain cases,
such as a left sided partial nephrectomy, the surgical team may have no choice but to posi tion
the patient on the right side. 30 When feasible, modifications such as left lateral decubitus
should be implemented to limit IVC compression and improve maternal cardiac output.29,31
A modification utilized specifically in 2 of the reported cases was the use of the openentry Hasson technique for entry into the peritoneum, in lieu of closed-entry Veress access.
Three authors utilized a direct vision entry into the abdomen to ensure atraumatic entry.

Specifically, Eichelberger et al., Mendevil et al., and Podolsky et al. used 2-mm trocar and 2-mm
laparoscope, 5-mm laparoscope, and 12-mm trocar, respectively. 5,12,32 Under typical
conditions, there is no significant difference in major complication rates between these
techniques and mode of entry is typically determined by surgeon preference .33-36 However, in
the setting of pregnancy, there was concern in some studies that the Veress needle could injure
the uterus on penetration, as it is a blind approach to gaining abdominal access. Yet, as seen in
several of the reported studies, Veress access was successful without any major complications.
Therefore, we conclude that all modes of peritoneal access are acceptable, so long as there is
proper compensation for the size of the gravid uterus. If entry is obtained in the upper
abdomen, above the level of the gravid uterus, then the risk of injury to the uterus is minimized
and surgeon preference should dictate technique. However, if the entry is planned in the lower
abdomen, consideration should be given to an open-entry technique despite a lack of evidence
to support its absolute necessity.
With regard to port placement and intra-operative technique, additional modifications
may be required. In the majority of the cases identified in this review, there were no significant
modifications to port placement (Table 2). In the few cases where modifications were
specifically commented on, the inferior ports were shifted slightly cephalad to ensure safe port
placement.13,37 However, per standard guidelines, all ports in all studies were placed under
direct vision – and the cephalad ports were placed first to ensure adequate visualization. Of
note, there were no major intra-operative modifications to technique for the urologic cases; for
the gynecologic cases, there were slight modifications worth noting. First, and somewhat
obvious, a uterine manipulator is contraindicated in these cases. In order to displace the uterus

for better visualization, Al-Badawi et al. utilized a 10-mm dismantling fan retractor for traction
as it was believed this would be the most atraumatic instrument for safely applying some
traction on the gravid uterus. In contrast, Chen et al. utilized a grasper via the accessory port to
lift and hold the round ligament to create enough working space. None of the other series
noted specific modifications to account for the gravid uterus.
Due to the nature of systematic reviews, the findings herein are subject to potential
publication bias. It may be that RALS surgeries in pregnancy have been performed but have
simply not been reported in the literature. Considering RALS is sometimes performed over
traditional laparoscopic surgery secondary to surgeon preference, underreporting may occur
due to surgeons not considering this procedure novel, but rather a technique interchangeable
with laparoscopy. This could lead to unreported outcomes, complications and surgical
modifications that are not accounted for in our review. Additionally, the studies included lack
substantial and uniform outcome data, such as the Clavien-Dindo classification 38. While overall
safety cannot be established, no cases in this review showed significant post-operative
complications or maternal-fetal complications.
Perhaps owing to the paucity of cases, no current guidelines exist in regard to RALS
within this population. Although commonalities clearly exist, the lack of standards is made
apparent by the variation in surgical modifications exhibited by the cases in our review. Our
review is of particular importance due to the fact that robotic urologic surgeries now exceed
laparoscopic surgeries in terms of volume.1 As robotics become a larger part of the field of
urology, a larger number of urology trainees will be increasingly comfortable with robotic

surgery rather than laparoscopic procedures. This will continue the trend toward robotics, as it
has been established that surgeons trained in certain procedures are more likely to perform
these procedures in their future practice. 39 As RALS becomes the de facto intervention due to
surgeon’s preference, it is important to validate its implementation in the pregnant populat ion.
Switching to a laparoscopic approach for the sole indication of pregnancy may present
suboptimal conditions if the physician is more comfortable with a robotic approach. Our results
highlight the need for further research to address the safety, efficacy and application of RALS in
pregnancy.

Conclusion:
Our review demonstrates the rarity of RALS in pregnant patients for non-obstetrical
indications. Based on the published literature, our review demonstrates that RALS could be a
safe and effective in pregnancy. However, in order to conclusively evaluate the safety,
superiority, or inferiority of non-obstetric RALS versus traditional laparoscopic surgery in the
pregnant population, further studies are necessary. As robotic surgery becomes more
ubiquitous within urologic and gynecologic training, RALS may be implemented on the basis of
surgeon preference and comfort. Therefore, we encourage tertiary care centers performing
non-obstetrical RALS to publish their pregnancy outcomes and complication rate s in order to
build an evidence-base to guide future practice.

Figure 1 – Flow diagram of studies identified in the systematic review 4
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Figure 1

Table 1. Clinical and surgical information of non-obstetrical RALS in pregnancy
# Author
Age
Indication for
Procedure type/
GA
Durati Complicati
surgery
Management
at
on,
ons
Parit
surg
EBL
y
ery

Discha
rge

Final
pathology

Maternal-fetal
outcomes

None

POD1

No residual
disease,
stage 1-A

Vaginal delivery,
healthy neonate, birth
weight 3200 g; CT scan
2 months postpartum
showed no evidence of
recurrence

None

POD1

Residual
disease in
left ovary,
stage 1-A

NR

None

POD1

Mature
teratoma

Vaginal delivery at
term, healthy neonate,

Ovarian:
1

AlBadaw
i

29
G3P
2

Endometrioid
adenocarcinoma
grade 1

Right
oophorectomy,
infracolic
omentectomy,
multiple
peritoneal
biopsies

17
wks

Adult type granulosa
cell tumor

Left salpingooophorectomy,
infracolic
omentectomy,
multiple
peritoneal
biopsies

17
wks

Left salpingooophorectomy

14
wks

2011

2

39
G5P
4

3

Baldwi
n

22
G1P

6.8x4.4x6.5 cm left
ovary with large

78
min
<100
cc

68
min
<100
cc

113
min

4

5

2011

0

solid component

with staging &
pelvic washings

Carter

46

2011

G3P
2

14 cm enlarging left
adnexal mass

Left ovarian
cystectomy

38
G3P
2

6

19
G1P
0

7

25
G1P
0

NR

20
wks

95
min
15 cc

with
negative
pelvic
washings

birth weight 3430 g;
Apgar score 9’-9’

None at 2
wks postop

POD1

Benign
mucinous
cystadeno
ma

NR

10x6x13 cm left
ovarian enlarging
cyst

Left ovarian
cystectomy

15
wks

95
min
10 cc

Pain at
trocar
sight at 2wks postop

POD1

Benign
mixed
epithelial
cystadeno
ma

NR

15 cm right ovarian
mass

Right ovarian
cystectomy

15
wks

92
min

None

NR

Mature
cystic
teratoma

NR

None

NR

Benign
serous
cystadeno
ma

NR

15 cc
Painful 16 cm right
ovarian cyst

Right ovarian
cystectomy

15
wks

86
min
minim
al

8

23
G2P
1

9

21

Painful 18 cm left
ovarian mass

Chen

36

2015

G2P
1

28.5
±
5.2

153
min

None

NR

Benign
mucinous
epithelial
cystadeno
ma

Term pregnancy

15 cm ovarian mass

Ovarian
cystectomy

21
wks

196
min
minim
al

None at 2
wks postop

NR

Benign
mucinous
cystadeno
ma

PPROM at 30 wks

Painful 5.2x4.3x7.8
cm left ovarian
tumor

Left salpingooophorectomy,
bilateral PLND,
omentectomy,
pelvic washings

14
wks

145
min

Chemothe
rapy (5
courses
carboplati
n and
paclitaxel)
began at
18 wks

NR

Ovarian
endometroi
d
adenocarci
noma
(grade 2)
with
positive
cytology
(pT1cN0M
x) stage1C

Cesarean delivery at 37
wks for cancer staging,
healthy neonate, birth
weight 2888 g; Apgar
score 9’-9’; CT scan at
18 months postpartum
showed no local
recurrence, CA-125
15.56 U/ml

None

POD0

Mature
teratoma
n=10,
serous

Mean gestational age at
delivery 38.6 wks with
one preterm at <37
wks; mean birth weight

CA-125: 414 U/ml

1 Eichel
1- ber2 gera

19
wks

15 cc

G1P
0
1
0

Left ovarian
cystectomy

Adnexal mass with
mean diameter of
7.3 ±2.4 cm

Oophorectomy
19.6
n=2, cystectomy wks
n=17
(rang
e 17-

<50
cc

77
min
(rang
e 60-

9

2012
n=19

3
0

Mendiv
il
2013

3
1

3
2

G2P
0

32
G1P
1
35
G1P
1
31
G5P

21.4)

cystadeno
3009 gb
ma n=3,
endometrio
ma n=1,
mucinous
cystadeno
ma n=2,
benign cyst
n=1, tumor
of low
malignant
potential
n=3

93)
10 cc
(rang
e 020)

Painful 10 cm
enlarging pelvic
mass

Right salpingooophorectomy

16
wks

Painful 6 cm right
ovarian complex
mass

Right ovarian
cystectomy

Bilateral complex
pelvic masses

Left salpingo22
oophorectomy & wks
right partial

124.2
min

None

NR

Immature
teratoma,
stage 1,
grade 3

Vaginal delivery at 37
wks, healthy neonate,
birth weight 2892 g;
Apgar score 9 at 5 min

None

NR

Ovarian
endometrio
ma

Vaginal delivery at 39
wks, healthy neonate,
birth weight 3024 g;
Apgar score 9 at 5 min

None

NR

Benign,
hemorrhagi

Vaginal delivery at 38
wks, healthy neonate,
birth weight 2956 g;

25 cc
16
wks

90
min
25 cc
159
min

1

3
3

37
G1P
1

ovarian
cystectomy
Painful enlarging
right ovarian lesion

Right ovarian
cystectomy

100
cc
23
wks

85.2
min
10 cc

c cyst

Apgar score 8 at 5 min

Post-op
pneumoni
a
requiring
readmissi
on and
antibiotics

NR

Mucinous
cystadeno
ma

Vaginal delivery at 39
wks, healthy neonate,
birth weight 3030 g;
Apgar score 9 at 5 min

None

POD1

Adrenocorti
cal
adenoma

Cesarean delivery for
failure to progress at 39
wks, healthy neonate,
birth weight 2800 g;
Apgar 8-9, POD3 preeclampsia with severe
features

None

NR

Benign
adrenocorti

Scheduled cesarean
delivery at 36 wks,

Urologic:
3
4

3
5

Capell
a

33

2020

G6P
3

Nassi

26

4.2 cm right adrenal
lesion

Right
adrenalectomy

19
wks

Perioperative
dexamethasone
, post-op
prednisone,
during cesarean
hydrocortisone,
postpartum
prednisone
Cushing syndrome
with 3.4x2.8x3.7 cm

Right
adrenalectomy

118
min
50 cc

21
wks

NR

3
6

2015

NR

right adrenal mass

Intra-op
hydrocortisone,
post-op and
postpartum
steroid therapy

Park

36

2008

G1P
0

4.0 cm left renal
mass

Left partial
nephrectomy

NR

14
wks

165
None
min
(warm
ische
mia=2
8 min)

cal
adenoma

healthy neonate, birth
weight 2550 g; normal
Apgar; ACTH normal at
6 months postpartum

POD5

Convention
al-type
RCC with
Fuhrman
nuclear
grade 3,
stage T1a

Remainder of
pregnancy was
uneventful

POD4

Benign
pheochrom
ocytoma

Cesarean delivery after
failed induction for
oligohydramnios at 39
wks, healthy neonate;
blood pressure stable at
one month postpartum

100
cc
3
7

Podols
ky
2010

34
G1P
0

5 cm right adrenal
mass
Urine
normetanephrine
8776 mcg/24h

Right
adrenalectomy
via
transperitoneal
access
Pre-op
phenoxybenzam
ine 20 mg QID
and labetalol

21
wks

270
min
250
cc

None

100 mg TID
3
8

Ramire 35
z
NR
2015

6.5 cm right renal
mass

Right partial
nephrectomy

20
wks

253
None
min
(warm
ische
mia
36
min)

POD6

Chromoph
obe RCC
with
negative
margins
(T1b)

Vaginal delivery at
term, healthy neonate

120
cc
Total=
38
patient
s

30.0
+
6.3
G1=
9
>G1
=

Ovarian=33
Urologic=5

Mea
n
18.7
wks c
rang
e:
1423

Mean
104
minc
(n=37
)
EBL:

27

<50=
30

NR=
2

51200=5
>200

Pneumoni
a=1

<1=25

Vaginal delivery: n=8

>1=3

Cesarean: n=4

NR=10

NR=26

=1

Abbreviations: GA, gestational age, NR, not reported, POD, post-op day, PPROM, preterm premature rupture of
membranes, PLND, pelvic lymph node dissection, QID, four times a day, RCC, renal cell carcinoma, TID, three times a
day, wks, weeks
a
Data was reported in aggregate (n=19)
b
Only 8 of the 19 subjects had maternal-fetal information available
c
Standard deviation could not be calculated because Eichelberger et al. reported their data as aggregate with 19 patients.
They did not report standard deviation for GA at surgery and surgical duration

Table 2. Surgical Modifications for non-obstetrical RALS in pregnancy
Author
Anesthesia
Access
Port Placement
Ovarian:
Al-Badawi
2011

- Avoided
use of
nitrous
oxide
- End- tidal
CO2 kept
~33–35
mmHg

NR

Baldwin
2011

NR

Hasson
technique

Carter
2011

NR

Hasson
technique

- One 12-mm assistant
port placed at the left
upper quadrant (Palmer’s
point)
- Three robotic port sites
placed under direct vision
with an endoscopic
camera through the
assistant port
Secondary trocars
inserted under direct
visualization

NR

Positioning

Pneumoperitoneum

Other

NR

Limited to
12 mmHg

Utilized a 10-mm
dismantling fan
retractor for
traction for better
visualization

- Dorsal
lithotomy with a
right lateral tilt
allowing easier
access to the
left adnexa
-Trendelenburg
15–20°
NR

Limited to
12 mmHg

- Nasogastric
tube inserted into
the stomach
- No instruments
applied to the
cervix for uterine
manipulation

Limited to
12 mmHg

NR

Chen
2015

NR

NR

- Trocar setting at a higher NR
position suggested for
cases with large uterus or
pregnancy >13 weeks
- Adopting sites 6 cm
above the umbilicus for
the scope, & 8–10 cm
caudal-lateral to the scope
for the side arms

NR

Eichelberger
2012

NR

NR

NR

Midline 12-mm trocar
placed sufficiently above
the fundus followed by 2to 8-mm trocars placed at
10 cm to the right & left of
the midline trocar
NR

NR

Mendivil
2013

Direct vision
port
placement:
2-mm trocar
& 2-mm
laparoscope
Direct vision
port
placement:
5-mm
laparoscope

- No uterine
manipulator used
- Tocolytic agents
given before,
throughout & after
the surgery
- Utilized a
grasper via the
accessory port to
lift & hold the
round ligament
NR

NR

NR

NR

Veress
needle
NR

Mild cephalad deviation

NR

NR

NR

NR

Limited to
12 mmHg
NR

Veress
needle
Direct vision
port
placement:
12-mm

NR

NR

NR

First trocar placed in the
left upper quadrant or
subxiphoid area under
direct visualization

Left lateral
decubitus
position

Limited to
10 mmHg
Limited to
10-12
mmHg

Urologic:
Capella
2020
Nassi
2015
Park
2008
Podolsky
2010

NR
NR
NR
NR

NR

Continuous
monitoring for
acidosis

Ramirez
2015

NR

trocar
Veress
needle

Adjusted superiolaterally

Left lateral
decubitus
position

Limited to
12 mmHg

Avoided the use
of mannitol

Abbreviations: NR, not reported

